114 related articles for article (PubMed ID: 1678082)
21. Comparative study of the circadian rhythmicity in the urinary concentration of glycosaminoglycans in patients of calcium oxalate nephrolithiasis and in healthy adults.
Sidhu H; Thind SK; Nath R; Vaidyanathan S; Hemal AK; Mandal AK; Krishan K
Urol Int; 1989; 44(4):218-21. PubMed ID: 2800054
[TBL] [Abstract][Full Text] [Related]
22. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration.
Campieri C; Campieri M; Bertuzzi V; Swennen E; Matteuzzi D; Stefoni S; Pirovano F; Centi C; Ulisse S; Famularo G; De Simone C
Kidney Int; 2001 Sep; 60(3):1097-105. PubMed ID: 11532105
[TBL] [Abstract][Full Text] [Related]
23. [Oxalate as a promoter in calcium oxalate nephrolithiasis].
Yamakawa K; Katou T; Arima K; Yanagawa M; Kawamura J
Hinyokika Kiyo; 1991 Oct; 37(10):1111-4. PubMed ID: 1755400
[TBL] [Abstract][Full Text] [Related]
24. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of oxalate cellular transport in idiopathic calcium nephrolithiasis.
Baggio B; Gambaro G
J Nephrol; 1998; 11 Suppl 1():63-5. PubMed ID: 9604815
[No Abstract] [Full Text] [Related]
26. Renal excretion of oxalate in patients with chronic renal failure or nephrolithiasis.
Chen SM; Chen TW; Lee YH; Chu WY; Young TK
J Formos Med Assoc; 1990 Aug; 89(8):651-6. PubMed ID: 1981225
[TBL] [Abstract][Full Text] [Related]
27. The effect of fenquizone on the urinary inhibitors of calcium oxalate urolithiasis.
Cupisti A; Ciardella F; Morelli E; Dani L; Lupetti S; Luchi S; Meola M; Barsotti G
Contrib Nephrol; 1987; 58():184-6. PubMed ID: 3691123
[No Abstract] [Full Text] [Related]
28. Nephrolithiasis and intestinal disease.
Dobbins JW
J Clin Gastroenterol; 1985 Feb; 7(1):21-4. PubMed ID: 3980960
[TBL] [Abstract][Full Text] [Related]
29. [Diagnosis of intestinal oxalate hyperabsorption in patients with idiopathic recurrent calcium oxalate urinary calculi].
Berg W; Haerting R; Bothor C; Meinig S; Eschholz A; Schulze HP
Urologe A; 1990 May; 29(3):148-51. PubMed ID: 2382323
[TBL] [Abstract][Full Text] [Related]
30. Schedule of taking calcium supplement and the risk of nephrolithiasis.
Domrongkitchaiporn S; Sopassathit W; Stitchantrakul W; Prapaipanich S; Ingsathit A; Rajatanavin R
Kidney Int; 2004 May; 65(5):1835-41. PubMed ID: 15086924
[TBL] [Abstract][Full Text] [Related]
31. The variability and dietary dependence of urinary oxalate excretion in recurrent calcium stone formers.
Brown JM; Stratmann G; Cowley DM; Mottram BM; Chalmers AH
Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():385-90. PubMed ID: 3662388
[TBL] [Abstract][Full Text] [Related]
32. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
[TBL] [Abstract][Full Text] [Related]
33. Renal injury mediated calcium oxalate nephrolithiasis: role of lipid peroxidation.
Muthukumar A; Selvam R
Ren Fail; 1997 May; 19(3):401-8. PubMed ID: 9154657
[TBL] [Abstract][Full Text] [Related]
34. Dietary manipulation of delta-6-desaturase modifies phospholipid arachidonic acid levels and the urinary excretion of calcium and oxalate in the rat: insight in calcium lithogenesis.
Gambaro G; Bordoni A; Hrelia S; Bordin L; Biagi P; Semplicini A; Clari G; Manzato E; Baggio B
J Lab Clin Med; 2000 Jan; 135(1):89-95. PubMed ID: 10638699
[TBL] [Abstract][Full Text] [Related]
35. Intestinal and renal handling of oxalate loads in normal individuals and stone formers.
Knight J; Holmes RP; Assimos DG
Urol Res; 2007 Jun; 35(3):111-7. PubMed ID: 17431604
[TBL] [Abstract][Full Text] [Related]
36. Hyperoxaluria in patients with idiopathic calcium nephrolithiasis.
Trinchieri A; Ostini F; Nespoli R; Rovera F; Zanetti G; Pisani E
J Nephrol; 1998; 11 Suppl 1():70-2. PubMed ID: 9604817
[TBL] [Abstract][Full Text] [Related]
37. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
Pak CY; Peterson R
Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
Baggio B; Gambaro G; Favaro S; Borsatti A
Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
[TBL] [Abstract][Full Text] [Related]
39. [Experimental evidence of magnesium salts for treatment of calcium oxalate nephrolithiasis in an animal model based on sodium oxalate and a cyclooxygenase 2 selective inhibitor].
Spasov AA; Iezhitsa IN; Kharitonova MV; Kravchenko MS; Snigur GL; Pisarev VB
Patol Fiziol Eksp Ter; 2013; (2):50-5. PubMed ID: 24000715
[TBL] [Abstract][Full Text] [Related]
40. Oxalate and renal stone formation.
Tiselius HG
Scand J Urol Nephrol Suppl; 1980; 53():135-48. PubMed ID: 6937989
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
